UBS Group’s FT Vest US Equity Enhance & Moderate Buffer ETF January XJAN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-1,325
Closed -$48.8K 11252
2025
Q4
$48.8K Sell
1,325
-1,717
-56% -$62.4K ﹤0.01% 7228
2025
Q3
$110K Sell
3,042
-6,284
-67% -$223K ﹤0.01% 7054
2025
Q2
$326K Buy
9,326
+404
+5% +$13.5K ﹤0.01% 6376
2025
Q1
$296K Buy
8,922
+3,875
+77% +$131K ﹤0.01% 6259
2024
Q4
$170K Buy
5,047
+628
+14% +$21K ﹤0.01% 6554
2024
Q3
$147K Buy
4,419
+4,411
+55,138% +$144K ﹤0.01% 6085
2024
Q2
$260 Buy
+8
New +$256 ﹤0.01% 9027

Other funds holding XJAN

UBS Group's XJAN Position: Q1 2026 in Review

UBS Group sold out of FT Vest US Equity Enhance & Moderate Buffer ETF January (XJAN) in Q1 2026, closing a stake of 1,325 shares — an estimated $48.8K sold.

UBS Group first reported a position in XJAN in Q2 2024 and held it in 7 quarters. The position peaked at $326K in Q2 2025. 31 funds tracked by Wall St. Rank hold XJAN as of Q1 2026.

  • UBS Group reported no remaining FT Vest US Equity Enhance & Moderate Buffer ETF January position as of Q1 2026 after selling out during the quarter.
  • UBS Group sold 1,325 FT Vest US Equity Enhance & Moderate Buffer ETF January shares in Q1 2026, an estimated $48.8K.
  • UBS Group first reported a position in FT Vest US Equity Enhance & Moderate Buffer ETF January in Q2 2024 and held it in 7 quarters.
  • UBS Group's FT Vest US Equity Enhance & Moderate Buffer ETF January position peaked at $326K in Q2 2025.
  • 31 funds tracked by Wall St. Rank held FT Vest US Equity Enhance & Moderate Buffer ETF January as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.